annual SGA:
$78.65M+$25.86M(+48.99%)Summary
- As of today (June 4, 2025), LGND annual SGA is $78.65 million, with the most recent change of +$25.86 million (+48.99%) on December 31, 2024.
- During the last 3 years, LGND annual SGA has risen by +$31.86 million (+68.10%).
- LGND annual SGA is now at all-time high.
Performance
LGND SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$18.80M-$6.80M(-26.57%)Summary
- As of today (June 4, 2025), LGND quarterly SGA is $18.80 million, with the most recent change of -$6.80 million (-26.57%) on March 31, 2025.
- Over the past year, LGND quarterly SGA has increased by +$7.85 million (+71.68%).
- LGND quarterly SGA is now -39.61% below its all-time high of $31.13 million, reached on December 31, 2022.
Performance
LGND quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$2.02B-$132.62M(-6.15%)Summary
- As of today (June 4, 2025), LGND TTM SGA is $2.02 billion, with the most recent change of -$132.62 million (-6.15%) on March 31, 2025.
- Over the past year, LGND TTM SGA has increased by +$1.97 billion (+3724.89%).
- LGND TTM SGA is now -6.33% below its all-time high of $2.16 billion.
Performance
LGND TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
LGND Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +49.0% | +71.7% | +3724.9% |
| 3 y3 years | +68.1% | +57.7% | +4259.8% |
| 5 y5 years | +87.8% | +103.0% | +4949.5% |
LGND Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.1% | -39.6% | +73.2% | -6.3% | +11.6% |
| 5 y | 5-year | at high | +87.8% | -39.6% | +166.9% | -6.3% | +31.2% |
| alltime | all time | at high | +1023.6% | -39.6% | +144.3% | -6.3% | +152.8% |
LGND Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $18.80M(-26.6%) | $86.50M(+10.0%) |
| Dec 2024 | $78.65M(+49.0%) | $25.61M(+4.6%) | $78.65M(+13.9%) |
| Sep 2024 | - | $24.48M(+38.9%) | $69.04M(+16.6%) |
| Jun 2024 | - | $17.62M(+60.9%) | $59.22M(+12.0%) |
| Mar 2024 | - | $10.95M(-31.5%) | $52.89M(+0.2%) |
| Dec 2023 | $52.79M(-24.7%) | $15.99M(+9.1%) | $52.79M(-22.3%) |
| Sep 2023 | - | $14.66M(+29.8%) | $67.93M(-0.4%) |
| Jun 2023 | - | $11.29M(+4.0%) | $68.19M(-1.2%) |
| Mar 2023 | - | $10.86M(-65.1%) | $68.99M(-1.5%) |
| Dec 2022 | $70.06M(+49.7%) | $31.13M(+108.7%) | $70.06M(+52.4%) |
| Sep 2022 | - | $14.92M(+23.4%) | $45.97M(+5.0%) |
| Jun 2022 | - | $12.09M(+1.4%) | $43.77M(-5.7%) |
| Mar 2022 | - | $11.93M(+69.3%) | $46.40M(-1.5%) |
| Dec 2021 | $46.79M(-22.0%) | $7.04M(-44.6%) | $47.09M(-28.3%) |
| Sep 2021 | - | $12.72M(-13.5%) | $65.70M(-3.4%) |
| Jun 2021 | - | $14.71M(+16.6%) | $68.01M(+7.3%) |
| Mar 2021 | - | $12.62M(-50.8%) | $63.37M(+5.6%) |
| Dec 2020 | $60.01M(+43.3%) | $25.66M(+70.8%) | $60.01M(+34.5%) |
| Sep 2020 | - | $15.02M(+49.2%) | $44.63M(+14.0%) |
| Jun 2020 | - | $10.07M(+8.7%) | $39.13M(-2.3%) |
| Mar 2020 | - | $9.26M(-9.9%) | $40.06M(-4.4%) |
| Dec 2019 | $41.88M(+11.0%) | $10.28M(+7.9%) | $41.88M(-2.1%) |
| Sep 2019 | - | $9.53M(-13.4%) | $42.77M(-0.3%) |
| Jun 2019 | - | $10.99M(-0.8%) | $42.88M(+4.1%) |
| Mar 2019 | - | $11.09M(-0.7%) | $41.18M(+9.1%) |
| Dec 2018 | $37.73M(+31.7%) | $11.16M(+15.9%) | $37.73M(+9.9%) |
| Sep 2018 | - | $9.63M(+3.6%) | $34.32M(+8.2%) |
| Jun 2018 | - | $9.29M(+21.6%) | $31.72M(+9.5%) |
| Mar 2018 | - | $7.64M(-1.4%) | $28.97M(+1.1%) |
| Dec 2017 | $28.65M(+3.6%) | $7.75M(+10.2%) | $28.65M(+3.4%) |
| Sep 2017 | - | $7.03M(+7.4%) | $27.70M(+1.8%) |
| Jun 2017 | - | $6.55M(-10.6%) | $27.22M(-2.5%) |
| Mar 2017 | - | $7.32M(+7.8%) | $27.90M(+0.9%) |
| Dec 2016 | $27.65M(+8.9%) | $6.79M(+3.7%) | $27.65M(-1.5%) |
| Sep 2016 | - | $6.55M(-9.5%) | $28.06M(+6.0%) |
| Jun 2016 | - | $7.24M(+2.4%) | $26.48M(+0.0%) |
| Mar 2016 | - | $7.07M(-1.9%) | $26.47M(+4.2%) |
| Dec 2015 | $25.40M(+12.5%) | $7.21M(+45.0%) | $25.40M(+7.1%) |
| Sep 2015 | - | $4.97M(-31.2%) | $23.71M(-7.0%) |
| Jun 2015 | - | $7.22M(+20.5%) | $25.48M(+8.5%) |
| Mar 2015 | - | $5.99M(+8.6%) | $23.49M(+4.1%) |
| Dec 2014 | $22.57M(+25.5%) | $5.52M(-18.2%) | $22.57M(+5.1%) |
| Sep 2014 | - | $6.74M(+28.7%) | $21.47M(+10.2%) |
| Jun 2014 | - | $5.24M(+3.3%) | $19.49M(+5.0%) |
| Mar 2014 | - | $5.07M(+14.8%) | $18.55M(+3.2%) |
| Dec 2013 | $17.98M(+14.0%) | $4.42M(-7.1%) | $17.98M(+1.2%) |
| Sep 2013 | - | $4.76M(+10.5%) | $17.77M(+2.6%) |
| Jun 2013 | - | $4.31M(-4.4%) | $17.32M(+2.7%) |
| Mar 2013 | - | $4.50M(+7.1%) | $16.87M(+6.9%) |
| Dec 2012 | $15.78M(+8.2%) | $4.20M(-2.4%) | $15.78M(+5.9%) |
| Sep 2012 | - | $4.31M(+11.6%) | $14.90M(+2.4%) |
| Jun 2012 | - | $3.86M(+12.9%) | $14.56M(+0.0%) |
| Mar 2012 | - | $3.42M(+2.8%) | $14.55M(-0.2%) |
| Dec 2011 | $14.58M(+13.7%) | $3.32M(-16.2%) | $14.58M(-1301.3%) |
| Sep 2011 | - | $3.96M(+2.8%) | -$1.21M(-108.8%) |
| Jun 2011 | - | $3.85M(+11.9%) | $13.79M(+4.3%) |
| Mar 2011 | - | $3.44M(-127.6%) | $13.23M(+3.1%) |
| Dec 2010 | $12.83M(-57.9%) | -$12.48M(-165.8%) | $12.83M(-54.7%) |
| Sep 2010 | - | $18.97M(+476.5%) | $28.33M(+4.9%) |
| Jun 2010 | - | $3.29M(+7.9%) | $27.01M(+1.7%) |
| Mar 2010 | - | $3.05M(+0.9%) | $26.55M(-12.4%) |
| Dec 2009 | $30.45M | $3.02M(-82.9%) | $30.32M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $17.65M(+523.5%) | $30.50M(+62.4%) |
| Jun 2009 | - | $2.83M(-58.5%) | $18.78M(-8.4%) |
| Mar 2009 | - | $6.82M(+112.6%) | $20.50M(-13.8%) |
| Dec 2008 | $23.79M(-21.8%) | $3.21M(-45.9%) | $23.79M(-2.7%) |
| Sep 2008 | - | $5.93M(+30.3%) | $24.45M(+4.6%) |
| Jun 2008 | - | $4.55M(-54.9%) | $23.38M(-11.3%) |
| Mar 2008 | - | $10.10M(+160.9%) | $26.34M(-13.4%) |
| Dec 2007 | $30.41M(-30.7%) | $3.87M(-20.3%) | $30.41M(-24.6%) |
| Sep 2007 | - | $4.86M(-35.4%) | $40.31M(-15.6%) |
| Jun 2007 | - | $7.52M(-46.9%) | $47.75M(-3.1%) |
| Mar 2007 | - | $14.17M(+2.9%) | $49.26M(+12.2%) |
| Dec 2006 | $43.91M(+89.8%) | $13.77M(+12.0%) | $43.91M(-456.0%) |
| Sep 2006 | - | $12.29M(+36.1%) | -$12.33M(+418.9%) |
| Jun 2006 | - | $9.03M(+2.5%) | -$2.38M(-115.1%) |
| Mar 2006 | - | $8.81M(-120.7%) | $15.71M(-53.6%) |
| Dec 2005 | $23.13M(-69.8%) | -$42.47M(-290.9%) | $33.85M(-57.9%) |
| Sep 2005 | - | $22.25M(-17.9%) | $80.46M(-4.2%) |
| Jun 2005 | - | $27.11M(+0.6%) | $84.03M(+2.4%) |
| Mar 2005 | - | $26.95M(+550.5%) | $82.03M(+7.2%) |
| Dec 2004 | $76.51M(+23.6%) | $4.14M(-83.9%) | $76.51M(-19.5%) |
| Sep 2004 | - | $25.81M(+2.8%) | $95.05M(+15.3%) |
| Jun 2004 | - | $25.12M(+17.2%) | $82.45M(+16.3%) |
| Mar 2004 | - | $21.44M(-5.5%) | $70.91M(+14.6%) |
| Dec 2003 | $61.90M(+48.0%) | $22.69M(+71.7%) | $61.90M(+23.0%) |
| Sep 2003 | - | $13.22M(-2.6%) | $50.34M(+5.1%) |
| Jun 2003 | - | $13.57M(+9.2%) | $47.89M(+7.4%) |
| Mar 2003 | - | $12.43M(+11.7%) | $44.59M(+6.6%) |
| Dec 2002 | $41.83M(+21.5%) | $11.12M(+3.3%) | $41.83M(+7.6%) |
| Sep 2002 | - | $10.77M(+4.7%) | $38.88M(+10.1%) |
| Jun 2002 | - | $10.28M(+6.4%) | $35.32M(+4.1%) |
| Mar 2002 | - | $9.66M(+18.1%) | $33.93M(-1.4%) |
| Dec 2001 | $34.43M(+0.9%) | $8.18M(+13.5%) | $34.43M(+0.0%) |
| Sep 2001 | - | $7.21M(-18.9%) | $34.42M(-3.8%) |
| Jun 2001 | - | $8.89M(-12.5%) | $35.78M(-1.9%) |
| Mar 2001 | - | $10.16M(+24.2%) | $36.47M(+6.9%) |
| Dec 2000 | $34.11M(+25.2%) | $8.18M(-4.5%) | $34.10M(+3.1%) |
| Sep 2000 | - | $8.56M(-10.6%) | $33.08M(+8.4%) |
| Jun 2000 | - | $9.57M(+22.8%) | $30.52M(+4.7%) |
| Mar 2000 | - | $7.79M(+8.9%) | $29.15M(+6.9%) |
| Dec 1999 | $27.26M(+64.2%) | $7.16M(+19.3%) | $27.26M(+1.7%) |
| Sep 1999 | - | $6.00M(-26.8%) | $26.80M(+8.9%) |
| Jun 1999 | - | $8.20M(+39.0%) | $24.60M(+24.9%) |
| Mar 1999 | - | $5.90M(-11.9%) | $19.70M(+18.7%) |
| Dec 1998 | $16.60M(+64.4%) | $6.70M(+76.3%) | $16.60M(+31.7%) |
| Sep 1998 | - | $3.80M(+15.2%) | $12.60M(+11.5%) |
| Jun 1998 | - | $3.30M(+17.9%) | $11.30M(+6.6%) |
| Mar 1998 | - | $2.80M(+3.7%) | $10.60M(+5.0%) |
| Dec 1997 | $10.10M(-1.0%) | $2.70M(+8.0%) | $10.10M(-1.9%) |
| Sep 1997 | - | $2.50M(-3.8%) | $10.30M(+4.0%) |
| Jun 1997 | - | $2.60M(+13.0%) | $9.90M(0.0%) |
| Mar 1997 | - | $2.30M(-20.7%) | $9.90M(-2.9%) |
| Dec 1996 | $10.20M(+27.5%) | $2.90M(+38.1%) | $10.20M(+9.7%) |
| Sep 1996 | - | $2.10M(-19.2%) | $9.30M(-1.1%) |
| Jun 1996 | - | $2.60M(0.0%) | $9.40M(+38.2%) |
| Mar 1996 | - | $2.60M(+30.0%) | $6.80M(+15.3%) |
| Dec 1995 | $8.00M(+14.3%) | $2.00M(-9.1%) | $5.90M(0.0%) |
| Sep 1995 | - | $2.20M(+29.4%) | $5.90M(-16.9%) |
| Mar 1995 | - | $1.70M(-15.0%) | $7.10M(+1.4%) |
| Dec 1994 | $7.00M | $2.00M(+17.6%) | $7.00M(+40.0%) |
| Sep 1994 | - | $1.70M(0.0%) | $5.00M(+51.5%) |
| Jun 1994 | - | $1.70M(+6.3%) | $3.30M(+106.3%) |
| Mar 1994 | - | $1.60M | $1.60M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual SGA?
- What is the all time high annual SGA for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual SGA year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly SGA?
- What is the all time high quarterly SGA for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly SGA year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM SGA?
- What is the all time high TTM SGA for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM SGA year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual SGA?
The current annual SGA of LGND is $78.65M
What is the all time high annual SGA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual SGA is $78.65M
What is Ligand Pharmaceuticals Incorporated annual SGA year-on-year change?
Over the past year, LGND annual SGA has changed by +$25.86M (+48.99%)
What is Ligand Pharmaceuticals Incorporated quarterly SGA?
The current quarterly SGA of LGND is $18.80M
What is the all time high quarterly SGA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly SGA is $31.13M
What is Ligand Pharmaceuticals Incorporated quarterly SGA year-on-year change?
Over the past year, LGND quarterly SGA has changed by +$7.85M (+71.68%)
What is Ligand Pharmaceuticals Incorporated TTM SGA?
The current TTM SGA of LGND is $2.02B
What is the all time high TTM SGA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM SGA is $2.16B
What is Ligand Pharmaceuticals Incorporated TTM SGA year-on-year change?
Over the past year, LGND TTM SGA has changed by +$1.97B (+3724.89%)